Onset of Effect, Changes in Airflow Obstruction and Lung Volume, and Health-Related Quality of Life Improvements with Benralizumab for Patients with Severe Eosinophilic Asthma: Phase IIIb Randomized, Controlled Trial (SOLANA)

Reynold A Panettieri Jr1 Pulmonary, Allergy and Critical Care Division, University of Pennsylvania, Philadelphia, PA, USACorrespondence[email protected]
View further author information

Tobias Welte2 Department of Respiratory Medicine, Member of the German Center of Lung Research, Medizinische Hochschule Hannover, Hannover, Germany

Kartik V Shenoy3 Department of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA, USAView further author information

Stephanie Korn4 Pulmonary Department, Universitätsmedizin Mainz, Langenbeckstr, Mainz, GermanyView further author information

Margret Jandl5 Hamburger Institut Für Therapieforschung, Hamburg, GermanyView further author information

Edward M Kerwin6 Clinical Trials Division, Clinical Research Institute of Southern Oregon (Crisor), Medford, OR, USA

Rosa Feijoo7 Departamento De Medicina Interna Oriente, Universidad De Chile, Santiago, ChileView further author information

Peter Barker8 Research and Development, AstraZeneca, Gaithersburg, MD, USAView further author information

Richard F Olsson9 R&D, Innovative Medicines and Early Development, Early Clinical Development, AstraZeneca, Gothenburg, SwedenView further author information

Ubaldo J Martin8 Research and Development, AstraZeneca, Gaithersburg, MD, USA

Your download is now in progress and you may close this window